Skip to main content

JPMORGAN CHASE & CO

Position in NVAX — Novavax Inc

CIK 19617 NEW YORK, NY

Position in NVAX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$720,506
+$108,380 QoQ
Shares Held
76,487
+1.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 14% Shared 0% None 86%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,919,879,903 across 425 Biotechnology names. NVAX ranks #188 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $720,506 76,487
2026-03-31 $612,126 75,200
2025-12-31 $485,216 72,205
2025-09-30 $633,065 73,018
2025-06-30 $530,905 84,271
2025-03-31 $525,547 81,989
2024-12-31 $615,669 76,576
2024-09-30 $1,008,819 79,875
2024-06-30 $1,062,362 83,915
2024-03-31 $565,428 118,291
2023-12-31 $769,026 160,214
2023-09-30 $973,974 134,527
2023-06-30 $1,022,806 137,659
2023-03-31 $632,521 91,273
2022-12-31 $465,396 45,272
2022-09-30 $946,217 51,990
2022-06-30 $2,931,046 56,991
2022-03-31 $5,180,242 70,336
2021-12-31 $8,592,638 60,059
2021-09-30 $53,773,722 259,388
2021-06-30 $17,032,992 80,227
2021-03-31 $83,817,616 462,289
2020-12-31 $25,672,388 230,225
2020-09-30 $15,496,973 143,027
2020-06-30 $1,637,827 19,650
2020-03-31 $5,900,861 434,526